相关数据集
Share of AI in drug discovery top 50 investors worldwide by region 2023
Distribution of leading 50 investors involved in AI in drug discovery worldwide as of 2023, by region
Statista80
历史文化遗产服务
面向镇江市文物保护单位,集成文物保护单位、非物质文化遗产、名镇名村、传统村落、古树名木等数据,并进行统一管理、更新,提供了统计分析、空间分析、属性查询等功能,为城乡历史文化遗产管理提供准确、全面的相关数据,提高各项保护措施的科学性与效率
江苏数据交易所70
Artificial Intelligence-Guided De Novo Molecular Design Targeting COVID-19
An extensive search for active therapeutic agents against the SARS-CoV-2 is being conducted across the globe. While computational docking simulations remain a popular method of choice for the in silic
Figshare2021-05-04 更新40
AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity
The anticancer agent irinotecan often induces severe delayed-onset diarrhea, inhibiting human carboxylesterase 2A (hCES2A) can significantly alleviate irinotecan-triggered gut toxicity (ITGT). This wo
Figshare2025-03-12 更新70
Autonomous Agentic AI Systems for Pharmaceutical Drug Discovery: A Multi-Agent Framework for Molecular Design and Optimization
Contemporary drug discovery represents an extraordinarily complex and capital-intensive scientific challenge, characterized by development timelines extending 10-15 years and clinical failure rates su
Figshare2025-08-06 更新50



